Download Correction No. 5

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Correction Number 5 Made to the List of Medications
An Act respecting prescription drug insurance
(R.S.Q., c. A-29.01, s. 60, 7th par., and s. 60.2; 2005, c. 40, s. 23)
In accordance with section 60.2 of the Act respecting prescription drug insurance, the
Conseil du médicament has notified the Régie de l’assurance maladie du Québec that
the Conseil has been informed of reductions in the prices of medications and of
changes in the manufacturer, name and identification number of medications.
Consequently, the Régie has made the required corrections to the List of Medications
attached to the Regulation respecting the List of medications covered by the basic
prescription drug insurance plan, made on 11 September 2008 by Order 2008-011 of
the Minister of Health and Social Services and published on 29 September 2008 on the
Régie's website.
The corrections set out in the Schedule attached hereto take effect on 17 December
2008.
Publication of these corrections on the website of the Régie de l’assurance maladie du
Québec imparts authentic value to them, in accordance with the last paragraph of
section 60 of the Act respecting prescription drug insurance.
Original signed by
Normand Julien
Secretary of the Régie de
l’assurance maladie du Québec
SCHEDULE
List of Medications – Edition 22 – Correction No. 5
Date of Coming Into Force: 17 December 2008
Reductions in the prices of the following medications (new package size costs
and unit prices):
24:06.06
FIBRIC ACID DERIVATIVES
MICROCOATED FENOFIBRATE X
Caps. or Tab.
160 mg
LPM
02246860
Apo-Feno-Super
Apotex
30
16.50
0.5500
02289091
Novo-Fenofibrate-S
Novopharm
30
16.50
0.5500
24:32.04
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEI)
LISINOPRIL HYDROCHLOROTHIAZIDE X
Tab.
20 mg -12.5 mg
LPM
02297744
Gen-Lisinopril HCTZ
Genpharm
30
12.02
0.4007
02301776
Novo-Lisinopril/HCTZ (Type
Z)
Novopharm
30
12.02
0.4007
02302373
Sandoz Lisinopril HCT
Sandoz
30
12.02
0.4007
28:08.04
NONSTEROIDAL ANTI- INFLAMMATORY AGENTS
DICLOFENAC SODIUM X
Ent.Tab.or L.A.Tab
25 mg / 75 mg L.A.
LPM
00808539
Novo-Difenac 25 mg
Novopharm
100
15.63
0.1563
02158582
Novo-Difenac SR 75 mg
Novopharm
100
46.89
0.4689
28:16.08
ANTIPSYCHOTIC AGENTS
QUETIAPINE (FUMARATE) X
Tab.
200 mg
02313936
Apo-Quetiapine
Apotex
500
661.65
1.3233
02316110
Co Quetiapine
Cobalt
500
661.65
1.3233
02307839
Gen-Quetiapine
Genpharm
100
132.33
1.3233
02284278
Novo-Quetiapine
Novopharm
100
132.33
1.3233
02296594
pms-Quetiapine
Phmscience
500
661.65
1.3233
02311747
ratio-Quetiapine
Ratiopharm
500
661.65
1.3233
02316722
Riva-Quetiapine
Riva
500
661.65
1.3233
Tab.
300 mg
02313944
Apo-Quetiapine
Apotex
500
965.60
1.9312
02316129
Co Quetiapine
Cobalt
500
965.60
1.9312
02284286
Novo-Quetiapine
Novopharm
100
193.12
1.9312
02296608
pms-Quetiapine
Phmscience
500
965.60
1.9312
02311755
ratio-Quetiapine
Ratiopharm
500
965.60
1.9312
02316730
Riva-Quetiapine
Riva
500
965.60
1.9312
Change in manufacturer:
28:16.08
ANTIPSYCHOTIC AGENTS
FLUPHENAZINE DECANOATE X
DIN or Billing
Code
00755575
Brand Name
Modecate
Concentre
Former
Manufacturer
Squibb
New
Manufacturer
B.M.S.
Correction of manufacturer's name:
8:12.16
PENICILLINS
PIPERACILLIN SODIUM/ TABACTAM SODIUM X
DIN
02305593
02305607
02305615
Brand Name
Piperacilline/Tazobactam
for injection
Piperacilline/Tazobactam
for injection
Piperacilline/Tazobactam
for injection
Former Name of
Manufacturer
P.P.C.
New Name of
Manufacturer
PPC
P.P.C.
PPC
P.P.C.
PPC
68:36.04
THYROID AGENTS
LEVOTHYROXINE (SODIUM) X
DIN or
Billing
Code
Brand Name,
Strength
Former
Manufacturer
New
Manufacturer
02264323
02264331
02264358
02264366
02264374
02264390
02264404
02264412
02264420
02264439
02264447
02264455
Euthyrox 0.025 mg
Euthyrox 0.05 mg
Euthyrox 0.075 mg
Euthyrox 0.088 mg
Euthyrox 0.1 mg
Euthyrox 0.112 mg
Euthyrox 0.125 mg
Euthyrox 0.137 mg
Euthyrox 0.15 mg
Euthyrox 0.175 mg
Euthyrox 0.2 mg
Euthyrox 0.3 mg
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Genpharm
Serono
Serono
Serono
Serono
Serono
Serono
Serono
Serono
Serono
Serono
Serono
Serono
Change in brand name:
36:26
DIABETES MELLITUS
QUANTITATIVE GLUCOSE BLOOD TEST
Brand Name
DIN Code
99100096
Before
Ascensia Contour
After
Contour
48:10.32
MAST-CELL STABILIZERS
CROMOGLICATE (SODIUM)
Brand Name
DIN Code
01950541
Cromolyn
Before
After
Rhinaris CS Anti-allergique
Correction of brand name:
28:08.08 (in French only)
OPIATE AGONISTS
METHADONE HYDROCHLORIDE Z
Brand Name
DIN Code
02247698
02247699
02247700
02247701
Métadol
Métadol
Métadol
Métadol
Before
Metadol
Metadol
Metadol
Metadol
After
68:20.08
INSULINS
ASPART INSULIN
Brand Name
DIN Code
02245397
02244353
Novorapid
Novorapid
Before
NovoRapid
NovoRapid
After
Change in DIN code and in brand name:
40:12
REPLACEMENT PREPARATIONS
CALCIUM CARBONATE/VITAMIN D
Former DIN or
Billing Code
02246065
New DIN or
Billing Code
80008566
Former
Brand Name
Cal-D-400
New Brand
Name
Pro-Cal-D-400
Addition of a manufacturer because of a change in the manufacturer of a brand
name (Euthyrox)
Appendix I – Manufacturers That Have Submitted Different Guaranteed Selling
Prices for Wholesalers and Pharmacists:
Difference between
pharmacist's GSP and
wholesaler's GSP
Manufacturer
* Serono
EMD Serono Canada Inc.
5%
Related documents